For research use only
| Cat No. | ABC-X0363C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Host Cell | MC38 |
| Source Organ | Colon |
| Disease | Colon Adenocarcinoma |
| Storage | Liquid Nitrogen |
MC38 cells stably overexpressing human ICAM1, suitable for research in tumor immunology, immune cell recruitment, and inflammatory signaling modulation.
ICAM1 MC38 Overexpression Cell Line is a genetically engineered model derived from selected murine colon adenocarcinoma (MC38) parental cell line based on customers’ requirement. ICAM1 MC38 overexpression cell line is generated by stable integration of exogenous human ICAM1 into MC38 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The ICAM1 gene encodes a cell surface adhesion molecule that plays key roles in leukocyte trafficking and immune responses. It is upregulated in inflammatory conditions and various malignancies, including colorectal and breast cancers. ICAM1-mediated interactions facilitate tumor infiltration by immune cells and have therapeutic implications in inflammation and immuno-oncology. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0363C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Colon |
| Disease | Colon Adenocarcinoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | MC38 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The ICAM1 MC38 Overexpression Cell Line serves as a powerful tool to investigate ICAM1-associated immunological pathways and tumor-immune interactions. This model enables mechanistic studies of immune cell adhesion, signaling, and cancer immunotherapy responses. It is utilized for evaluating ICAM1-targeted treatments and immune checkpoint strategies in preclinical research.